NCT02744495 - Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery | Biotech Hunter

Enrollment

502

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions

Postoperative VomitingPostoperative NauseaPostoperative Emesis

Interventions

DRUG

Betamethasone

Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone / Celestene (4mg) and/or droperidol / Droleptan (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm.

DRUG

Droperidol

Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone / Celestene (4mg) and/or droperidol / Droleptan (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm.

Trial Locations (1)

78150

Parly2, Le Chesnay